These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 7965671)
1. Product inhibition and dose-dependent bioavailability of propranolol in the isolated perfused rat liver preparation. Ghabrial H; Nand R; Stead CK; Smallwood RA; Morgan DJ J Pharm Sci; 1994 Jul; 83(7):931-6. PubMed ID: 7965671 [TBL] [Abstract][Full Text] [Related]
2. (S)-4'-hydroxypropranolol causes product inhibition and dose-dependent bioavailability of propranolol enantiomers in the isolated perfused rat liver and in rat liver microsomes. Nand RA; Ghabrial H; Smallwood RA; Morgan DJ Xenobiotica; 1996 Dec; 26(12):1249-61. PubMed ID: 9004455 [TBL] [Abstract][Full Text] [Related]
3. Fetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver. Ring JA; Ghabrial H; Ching MS; Shulkes A; Smallwood RA; Morgan DJ Drug Metab Dispos; 1995 Feb; 23(2):190-6. PubMed ID: 7736910 [TBL] [Abstract][Full Text] [Related]
4. Interaction between propranolol and amino acids in the single-pass isolated, perfused rat liver. Semple HA; Xia F Drug Metab Dispos; 1995 Aug; 23(8):794-8. PubMed ID: 7493544 [TBL] [Abstract][Full Text] [Related]
5. Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation. Morris ME; Yuen V; Tang BK; Pang KS J Pharmacol Exp Ther; 1988 May; 245(2):614-24. PubMed ID: 3367309 [TBL] [Abstract][Full Text] [Related]
6. Enzymatic basis for the non-linearity of hepatic elimination of propranolol in the isolated perfused rat liver. Ishida R; Suzuki K; Masubuchi Y; Narimatsu S; Fujita S; Suzuki T Biochem Pharmacol; 1992 Dec; 44(12):2281-8. PubMed ID: 1472093 [TBL] [Abstract][Full Text] [Related]
7. Neonatal hepatic propranolol elimination: studies in the isolated perfused neonatal sheep liver. Gow PJ; Treepongkaruna S; Ghabrial H; Shulkes A; Smallwood RA; Morgan DJ; Ching MS J Pharm Sci; 2000 May; 89(5):586-93. PubMed ID: 10756324 [TBL] [Abstract][Full Text] [Related]
8. Propranolol disposition in the single-pass isolated, perfused rat liver in the presence and absence of insulin and glucagon. Semple HA; Xia F Drug Metab Dispos; 1994; 22(6):822-6. PubMed ID: 7895597 [TBL] [Abstract][Full Text] [Related]
9. The effect of hypoxia on propranolol clearance during antegrade and retrograde flow in the isolated perfused rat liver preparation. Elliott SL; Morgan DJ; Angus PW; Ghabrial H; Watson RG; Smallwood RA Biochem Pharmacol; 1993 Feb; 45(3):573-8. PubMed ID: 8442756 [TBL] [Abstract][Full Text] [Related]
10. Propranolol elimination as described by the venous equilibrium model using flow perturbations in the isolated perfused rat liver. Smallwood RH; Mihaly GW; Smallwood RA; Morgan DJ J Pharm Sci; 1988 Apr; 77(4):330-3. PubMed ID: 3379592 [TBL] [Abstract][Full Text] [Related]
11. The effect of hypoxia and acidosis on propranolol clearance in the isolated perfused rat liver preparation. Elliott SL; Morgan DJ; Angus PW; Ghabrial H; Smallwood RA Biochem Pharmacol; 1993 Feb; 45(3):763-5. PubMed ID: 8442773 [TBL] [Abstract][Full Text] [Related]
12. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol-17 beta-(beta-D-glucuronide). Vore M; Durham S; Yeh S; Ganguly T Biochem Pharmacol; 1991 Feb; 41(3):431-7. PubMed ID: 1994901 [TBL] [Abstract][Full Text] [Related]
13. Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood. Terao N; Shen DD J Pharmacol Exp Ther; 1985 May; 233(2):277-84. PubMed ID: 3999018 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent hepatic handling of l-propranolol determined by multiple indicator dilution method: influence of tissue binding of l-propranolol on its hepatic elimination. Miyauchi S; Sawada Y; Iga T; Hanano M; Sugiyama Y Biol Pharm Bull; 1993 Oct; 16(10):1019-24. PubMed ID: 8287031 [TBL] [Abstract][Full Text] [Related]
15. Reduction of dimesna to mesna by the isolated perfused rat liver. Goren MP; Hsu LC; Li JT Cancer Res; 1998 Oct; 58(19):4358-62. PubMed ID: 9766664 [TBL] [Abstract][Full Text] [Related]
16. A priming dose of propranolol reduces the availability of a subsequent dose in the isolated perfused rat liver preparation. Ghabrial H; Sewell RB; Smallwood RA; Morgan DJ Clin Exp Pharmacol Physiol; 1998 Feb; 25(2):110-3. PubMed ID: 9493498 [TBL] [Abstract][Full Text] [Related]
17. Hepatic metabolism of vasoactive intestinal polypeptide (VIP) in the rat. Brook CW; Sewell RB; Shulkes A; Smallwood RA Regul Pept; 1988 Apr; 20(4):311-22. PubMed ID: 3368582 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and identification of 3-(4-hydroxy-1-naphthoxy)lactic acid as a metabolite of propranolol in the rat, in man, and in the rat liver 9000 g supernatant fraction. Talaat RE; Nelson WL Drug Metab Dispos; 1986; 14(2):202-7. PubMed ID: 2870895 [TBL] [Abstract][Full Text] [Related]
19. Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions. Lo MW; Pond SM; Effeney DJ; Silber BM; Riegelman S; Tozer TN J Pharmacokinet Biopharm; 1984 Aug; 12(4):401-12. PubMed ID: 6527232 [TBL] [Abstract][Full Text] [Related]
20. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding. Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]